Return to Clinical Trials Search Results

A PHASE IIIb, DOUBLE-BLIND, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ALTEPLASE IN PATIENTS WITH MILD STROKE: RAPIDLY IMPROVING SYMPTOMS AND MINOR NEUROLOGICAL DEFICITS (PRISMS)

The primary objective of this study is to determine the efficacy of IV alteplase for treatment of AIS in patients with mild stroke (also known as minor neurologic deficit and rapidly improving stroke symptoms ), defined as an NIHSS score </= 5 and not clearly disabling, within 3 hours of last known well time as measured by the proportion of patients with mRS score of 0 or1 at Day 90.

The primary objective of this study is to determine the efficacy of IV alteplase for treatment of AIS in patients with mild stroke (also known as minor neurologic deficit and rapidly improving stroke symptoms ), defined as an NIHSS score </= 5 and not clearly disabling, within 3 hours of last known well time as measured by the proportion of patients with mRS score of 0 or1 at Day 90.